| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 11 |
| 1 | DOCETAXEL | 10 |
| 2 | DOCETAXEL ANHYDROUS | 10 |
| 3 | APIXABAN | 7 |
| 4 | CLOPIDOGREL BISULFATE | 7 |
| 5 | NOREPINEPHRINE BITARTRATE | 7 |
| 6 | SILDENAFIL | 7 |
| 7 | SILDENAFIL CITRATE | 7 |
| 8 | NOREPINEPHRINE (BITARTRATE) | 6 |
| 9 | OMEPRAZOLE MAGNESIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE, AND SODIUM PHOSPHATE DIBASIC DIHYDRATE | 1 | 0.0833 |
| 1 | DEXTROSE AND SODIUM CHLORIDE | 1 | 0.0060 |
| 2 | CLEVIDIPINE | 1 | 0.0027 |
| 3 | ISRADIPINE | 1 | 0.0018 |
| 4 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 5 | DOPAMINE HYDROCHLORIDE | 5 | 0.0013 |
| 6 | SODIUM HYALURONATE | 1 | 0.0012 |
| 7 | BIVALIRUDIN | 1 | 0.0010 |
| 8 | SODIUM CITRATE | 1 | 0.0008 |
| 9 | CHLOROTHIAZIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 13 |
| 1 | Catecholamine [EPC] | 12 |
| 2 | Corticosteroid [EPC] | 12 |
| 3 | Microtubule Inhibitor [EPC] | 12 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 5 | Factor Xa Inhibitor [EPC] | 10 |
| 6 | Prostacycline Vasodilator [EPC] | 7 |
| 7 | Endothelin Receptor Antagonist [EPC] | 6 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 6 |
| 9 | GLP-1 Receptor Agonist [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 3 | Catecholamine [EPC] | 12 | 0.0001 |
| 4 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Anticholinergic [EPC] | 2 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 3 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 12 | 0.0001 |